World's Best Scientists 2026 revealed!
Laurence Boumsell

Laurence Boumsell

D-Index & Metrics

Immunology

D-Index
63
Citations
11694
World Ranking
3068
National Ranking
132

Overview

Laurence Boumsell is affiliated with Inserm in France, a prominent institution known for its focus on biomedical research. Their work is situated within a research environment that emphasizes advanced studies in health and medical sciences.

Although specific details about recent papers are not available, it is clear that Laurence Boumsell contributes to ongoing research activities within their institution. Inserm, as a research organization, typically supports a wide range of projects in areas such as immunology, oncology, and molecular biology, indicating potential areas of engagement.

Information about frequent co-authors or collaborations is not listed, suggesting that either Laurence Boumsell works independently or the data on collaborative efforts has not been recorded. Similarly, no specific frequent publication venues are identified, which might imply publications in diverse journals or yet unrecorded venues.

There are no records of book publications, which points to a research focus primarily concentrated on articles and studies rather than extended monographic works.

Data on main fields of study, subfields, and main research topics for Laurence Boumsell are not provided. This limits the ability to define precise thematic areas of expertise or specialization. Likewise, no awards or honors have been noted, which reflects only on the available documentation rather than the full scope of the scientist's career.

Laurence Boumsell is currently active and not deceased, indicating ongoing potential contributions to their field. The absence of detailed public-facing information underscores a profile that is either early-career, highly specialized, or one whose detailed academic footprint is not yet broadly disseminated in open databases.

Best Publications

  • Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells

    Amal Nassif;Armand Bensussan;Laurence Boumsell;Aurelien Deniaud

  • Drug Specific Cytotoxic T-Cells in the Skin Lesions of a Patient with Toxic Epidermal Necrolysis

    Amal Nassif;Armand Bensussan;Guillaume Dorothée;Fathia Mami-Chouaib

  • Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation.

    Kathryn T. Hall;Laurence Boumsell;Joachim L. Schultze;Vassiliki A. Boussiotis

  • Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma

    Alain Bernard;Alain Bernard;Laurence Boumsell;Laurence Boumsell;Ellis L. Reinherz;Ellis L. Reinherz;Lee M. Nadler;Lee M. Nadler

  • CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival

    Silvia Deaglio;Tiziana Vaisitti;Luciana Bergui;Lisa Bonello

  • Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers.

    A Tazi;F Bouchonnet;M Grandsaigne;L Boumsell

  • Evaluation of the potential role of cytokines in toxic epidermal necrolysis.

    Amal Nassif;Homayoun Moslehi;Homayoun Moslehi;Sabine Le Gouvello;Martine Bagot

  • AN ANTIGEN SHARED BY A HUMAN T CELL SUBSET AND B CELL CHRONIC LYMPHOCYTIC LEUKEMIC CELLS Distribution on Normal and Malignant Lymphoid Cells

    L Boumsell;H Coppin;D Pham;B Raynal

  • Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury

    Li Zhu;Wolfgang Bergmeier;Jie Wu;Hong Jiang

  • CD molecules 2006 — Human cell differentiation molecules

    Heddy Zola;Bernadette Swart;Alison Banham;Simon Barry

  • CD158k/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome.

    Ewa Poszepczynska-Guigné;Valérie Schiavon;Michel D'Incan;Hamid Echchakir

  • Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma

    Martine Bagot;Hamid Echchakir;Hamid Echchakir;Fathia Mami-Chouaib;Fathia Mami-Chouaib;Marie-Hélène Delfau-Larue;Marie-Hélène Delfau-Larue

  • Biological Activity of Soluble CD100. II. Soluble CD100, Similarly to H-SemaIII, Inhibits Immune Cell Migration

    Stéphanie Delaire;Christian Billard;Rafaèle Tordjman;Alain Chédotal

  • T cell activation via CD2 [T, gp50] molecules: accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T11(1) epitopes.

    P Brottier;L Boumsell;C Gelin;A Bernard

  • Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes

    Anukanth Anumanthan;Armand Bensussan;Laurence Boumsell;Andreas D. Christ

  • Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity

    Philippe Le Bouteiller;Aliz Barakonyi;Jérome Giustiniani;Françoise Lenfant

  • CD molecules 2005: human cell differentiation molecules

    Heddy Zola;Bernadette Swart;Ian Nicholson;Bent Aasted

  • Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation.

    C. Bougeret;Indra Gusti Mansur;H. Dastot;M. Schmid

  • Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors

    L Le Cleach;S Delaire;L Boumsell;M Bagot

  • Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells

    Laurence Boumsell;A. Bernard;Virginia Lepage;L. Degos

  • CD4+ cutaneous T-cell lymphoma cells express the p140–killer cell immunoglobulin-like receptor

    Martine Bagot;Alessandro Moretta;Alessandro Moretta;Simona Sivori;Simona Sivori;Roberto Biassoni;Roberto Biassoni

Frequent Co-Authors

Armand Bensussan
Armand Bensussan Hôpital Saint-Louis
Alain Bernard
Alain Bernard Grenoble Alpes University
Jean Dausset
Jean Dausset Grenoble Alpes University
Jerome Ritz
Jerome Ritz Harvard University
Stuart F. Schlossman
Stuart F. Schlossman Harvard University
Georges Bismuth
Georges Bismuth Université Paris Cité
Martine Bagot
Martine Bagot Université Paris Cité
Lee M. Nadler
Lee M. Nadler Harvard University
Fathia Mami-Chouaib
Fathia Mami-Chouaib Institut Gustave Roussy
Timothy A. Springer
Timothy A. Springer Boston Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology and healthcare, pursuing related nursing degrees can open diverse career opportunities. Many professionals start with an accelerated nursing program to gain essential clinical skills quickly. Programs like 12-month accelerated nursing programs online for non nurses enable individuals without a nursing background to transition efficiently into the field.

Once you have a BSN, advancing to specialized roles is common. Accelerated pathways such as accelerated bsn programs for non nurses provide streamlined access for career changers. For those aiming to become nurse practitioners with a focus on acute care, a fnp to acute care np bridge program offers a tailored curriculum to meet this demand.

Moreover, pursuing an accelerated nurse practitioner program can significantly shorten the time to enter advanced practice roles. These pathways are ideal for motivated students who want to integrate Immunology knowledge with clinical expertise and impact patient care on a deeper level.

Best Scientists Citing Laurence Boumsell